CryoPort, Inc. (CYRX) Social Stream

Featured Post From StockTwits About CYRX

$CYRX Alliance for Regenerative Medicine: $1.6 Billion was invested into new cell & gene therapies last week by eight biotech companies - a new record.

Billions pouring into R&D assures new clients and revenue growth for Cryoport. Their build-out of global capacity is paying off. Freezer manufacturing unit MVE is adding a second shift at their Georgia USA facility. CryoPDP in Europe has seen inquiries rise 75% in a year. These two acquisitions alone added $42M to Q2 revenues. The Q2 dialogue between management and analysts demonstrates the depths that Cryoport has gone to assure they remain the world leader in this nascent industry.